2 papers
stat.ME2026
A Milestone-Based Framework for Characterizing Time-Varying Treatment Effects in Immunotherapy Trials
Yi-Cheng Tai, Weijing Wang, Jedd D. Wolchok +1
Immune checkpoint inhibitor--based therapies often produce heterogeneous survival responses, including early risk, delayed treatment benefit, and durable long-term survival in a su…
stat.ME2024
Estimand-based Inference in Presence of Long-Term Survivors
Yi-Cheng Tai, Weijing Wang, Martin T. Wells
In this article, we develop nonparametric inference methods for comparing survival data across two samples, which are beneficial for clinical trials of novel cancer therapies where…